LT002 | Booster

Dear Patient,

As we tread unknown waters, our elevated digital climate calls for a new next-generation therapeutic. The deployment of LT002, code-name Booster, has successfully passed digital engineering and is now pending production.

Limited quantities developed throughout beta test phases are now open to Collector Trials, at their own risk.

Subjects should be reminded to stay hydrated, hopeful, and actively pursuing their ambitions.

Lien Therapeutics remains committed to developing safe and effective therapies for those in need.

• Lien

====

Rendered using Clean Solar Energy 2200 x 2400 Resolution Reloaded by Savfk Cinematic 30FPS